Join our journey
A Norwegian life-science company solving one of the largest medical challenges we are facing.
20 minutes delay

Lifecare as an investment

Lifecare’s purpose is to develop and license technology for medical use, including facilitating the production and sale of medical devices. Today people with diabetes are dependent on a painful and more than 40-year-old technology. Lifecare’s solutions have the potential to revolutionise the field of continuous glucose measurement for more the more than 450 million people living with diabetes.

 

Top 5 shareholders

Updated November 21, 2022
Name
Holdings
Share
Citizen
Teigland Eiendom AS
24 691 829
20.96 %
NOR
Lacal AS
18 187 712
15.44 %
NOR
VPF Nordea Avkastning
8 974 413
7.62 %
NOR
Spit Air AS
3 087 735
2.62 %
NOR
Westhawk AS
3 018 480
2.56 %
NOR
Swipe for more data

Contact

Investor relations